Tacalyx
Tacalyx is an antibodies for cancer founded in 2019.
2
Funding Rounds
$15.3m
Money raised
Funding series
Funding Series Analysis
The company Tacalyx has raised a total of $7.7m in funding over 2 rounds.
Key Insights:
- Tacalyx Seed round, September 2019: $7.7m
- Tacalyx funding round, September 2019: $7.6m
Tacalyx Seed round, September 2019
$7.7m
Tacalyx funding round, September 2019
$7.6m
Industries
Tacalyx is active in the following industries: